|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
1.590 +0.010 (+0.633%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 6,355 | (59,447) | (133,495) | (182,066) |
| Net Cash from / (used in) Investing Activities | -- | 229,668 | (622) | (720,809) | 1,029,771 |
| Net Cash from / (used in) Financing Activities | -- | (218,774) | (184,063) | (120,548) | 81,690 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 17,249 | (244,132) | (974,852) | 929,395 |
| Cash & Cash Equivalents at beginning of period | -- | 252,917 | 495,425 | 1,455,454 | 535,849 |
| Effect of Foreign Exchange Rate Changes | -- | (11,021) | 1,624 | 14,823 | (9,790) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 259,145 | 252,917 | 495,425 | 1,455,454 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 43,294 |
| %Change | -- |
| EPS / (LPS) | RMB 0.070 |
| NBV Per Share (¥) | RMB 1.280 |